🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of the study was to investigate the safety and tolera...
Status
Completed
Location
Multiple Locations
Start Date
2002-08
Trial ID
NCT00224783
This study tests the safety and effectiveness of a flu vaccine in school ch...
Status
Completed
Location
Pedro A. Piedra, M.D.
Start Date
TBD
Trial ID
NCT00001127
Treatments Being Tested
The primary objective of this study was to perform a variety of assays on b...
Status
Completed
Location
David M. Radin, MD
Start Date
2001-09
Trial ID
NCT00192309
The purpose of this clinical study was to evaluate immune responses measuri...
Status
Completed
Location
West Coast Medical Associates
Start Date
2001-07
Trial ID
NCT00192153
Treatments Being Tested
The purpose of this study is to determine the efficacy of the liquid formul...
Status
Completed
Location
Multiple Locations
Start Date
2002-03
Trial ID
NCT00192400
Treatments Being Tested
To demonstrate that the efficacy over a defined surveillance period against...
Status
Completed
Location
Docnor House
Start Date
2002-03
Trial ID
NCT00192413
Treatments Being Tested
The purpose of this study is to determine the efficacy, safety and tolerabi...
Status
Completed
Location
Department of Family & Primary Care, Faculty of Medicine, University of Stellenbosch
Start Date
2001-04
Trial ID
NCT00217230
Treatments Being Tested
The purpose of this study is to describe the level of serum antibody confer...
Status
Completed
Location
Wee Care Pediatrics
Start Date
2005-05
Trial ID
NCT00111579
The primary objective of this study is to estimate the relative efficacy an...
Status
Completed
Location
Clinical Research Consultants, Inc
Start Date
2004-10
Trial ID
NCT00128167
Treatments Being Tested
Trial to compare the safety and tolerability of one and two doses of influe...
Status
Completed
Location
University of Tampere
Start Date
2002-05
Trial ID
NCT00192348
Treatments Being Tested